Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

NCT01095796 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

707

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV
HIV Infections

Interventions

DRUG: Stribild
DRUG: Atripla
DRUG: Stribild Placebo
DRUG: Atripla Placebo

Sponsor

Gilead Sciences